BioBeats is an adaptive media company.
We build technologies that respond to physiologic data and learn from how you interact with them, to help people live more engaging, healthier lives.
We are currently developing programmes for entertainment, consumer health and wellness and clinical medicine.
Our first app ‘Pulse’ was awarded the 2013 EchoNest prize at SXSW and was in the top three finalists in the Music Accelerator. Our adaptive health technologies are built on a cloud-based responsive platform designed to support the management of chronic conditions and general wellness.
Our team is based in San Francisco, London and Pisa, which allows us to understand the nuances of healthcare in the both the US and Europe.
Funding Rounds (3) - $3.23MUpdate
Current Team (4)Update
|May 25, 2016||Med City News - Q&A: As Wellth raises $2M, CEO talks fundraise, advice, ambitions|
|Apr 27, 2016||Tech City News - BioBeats closes $2.28m funding round led by White Cloud Capital|
|Apr 26, 2016||Business Wire - BioBeats raises $2.28m to quantify personal and corporate wellness with machine learning|
|Apr 26, 2016||PE HUB - White Cloud Capital leads $2.28 mln investment in BioBeats|
|Apr 26, 2016||Med City News - BioBeats stress assessment app is just one part of digital health’s stress subsector|
|Apr 22, 2016||StrictlyVC - StrictlyVC: April 22, 2016|
|Apr 22, 2016||TechCrunch - BioBeats raises $2.28M for its platform to replace human stress therapists|
|Apr 22, 2016||Vator.tv - Daily funding roundup - April 22, 2016|
6-8 Bonhill Street
London, EC2A 4BX
Largo B. Pontecorvo
Pisa, 3 56127
450 North Roxbury Drive
Beverly Hills, CA 90210
40 Mortimer St
London, England W1W7RQ
450 N Roxbury Drive
Berkeley, CA 94702-1764